Plc Astrazeneca's Net Worth
$812 Million
Who is Plc Astrazeneca?
Plc Astrazeneca has an estimated net worth of $812 Million. This is based on reported shares across multiple companies, which include Viela Bio, Inc., Aevi Genomic Medicine, Inc., PhaseBio Pharmaceuticals Inc, Entasis Therapeutics Holdings Inc., ALBIREO PHARMA, INC., Regulus Therapeutics Inc., and Ardea Biosciences, Inc./DE.
SEC CIK
Plc Astrazeneca's CIK is 0000901832
Past Insider Trading and Trends
2018 was Plc Astrazeneca's most active year for acquiring shares with 5 total transactions. Plc Astrazeneca's most active month to acquire stocks was the month of September. 2018 was Plc Astrazeneca's most active year for disposing of shares, totalling 5 transactions. Plc Astrazeneca's most active month to dispose stocks was the month of September. 2019 saw Plc Astrazeneca paying a total of $8,075,000.00 for 27,597,224 shares, this is the most they've acquired in one year. In 2021 Plc Astrazeneca cashed out on 14,650,334 shares for a total of $776,467,702.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Viela Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.65M |
$53.00 | -$776,467,702.00 |
0
|
Mar 15
| |||
Form 4
| +146,503,240.00% | 14.65M |
$19.00 |
—
| 14.65M |
Oct 7
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aevi Genomic Medicine, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.95M |
—
|
—
| 12.95M |
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.0002
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3M |
$5.00 |
—
| 3M |
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entasis Therapeutics Holdings Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +54,121,275.00% | 2.16M |
$15.00 |
—
| 2.16M |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALBIREO PHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -49.60% | -500.00K |
$21.40 | -$10,700,000.00 | 508.14K |
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||